Therapeutic combination of a VEGF antagonist and anti-hypertensive agent
US7354581B2 · kind B2 · utility
40Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2006 |
| Grant date | Apr 8, 2008 |
| Priority date | — |
| Expiry date | Sep 17, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compositions and methods for treating a disease or condition related to angiogenesis with a vascular endothelial growth factor (VEGF) inhibitor and one or more anti-hypertensive agent(s). The method of the invention is useful for preventing the development of hypertension and/or reducing hypertension in a subject treated with a VEGF inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.